...
首页> 外文期刊>Medical Physics >Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators.
【24h】

Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators.

机译:来自现代Varian,Siemens和Elekta Linacs的次要中子谱,用多叶准直器。

获取原文
获取原文并翻译 | 示例
           

摘要

Neutrons are a by-product of high-energy x-ray radiation therapy (threshold for [gamma,n] reactions in high-Z material -7 MeV). Neutron production varies depending on photon beam energy as well as on the manufacturer of the accelerator. Neutron production from modern linear accelerators (linacs) has not been extensively compared, particularly in terms of the differences in the strategies that various manufacturers have used to implement multileaf collimators (MLCs) into their linac designs. However, such information is necessary to determine neutron dose equivalents for different linacs and to calculate vault shielding requirements. The purpose of the current study, therefore, was to measure the neutron spectra from the most up-to-date linacs from three manufacturers: Varian 21EX operating at 15, 18, and 20 MV, Siemens ONCOR operating at 15 and 18 MV, and Elekta Precise operating at 15 and 18 MV. Neutron production was measured by means of gold foil activation in Bonner spheres. Based on the measurements, the authors determined neutron spectra and calculated the average energy, total neutron fluence, ambient dose equivalent, and neutron source strength. The shapes of the neutron spectra did not change significantly between accelerators or even as a function of treatment energy. However, the neutron fluence, and therefore the ambient dose equivalent, did vary, increasing with increasing treatment energy. For a given nominal treatment energy, these values were always highest for the Varian linac. The current study thus offers medical physicists extensive information about the neutron production of MLC-equipped linacs currently in operation and provides them information vital for accurate comparison and prediction of neutron dose equivalents and calculation of vault shielding requirements.
机译:中子是高能量X射线放射治疗的副产物(高Z材料-7MeV的γ,N]反应的阈值)。中子制作根据光子束能量以及加速器的制造商而变化。来自现代线性加速器(LINACS)的中子生产尚未进行广泛的比较,特别是在各种制造商已经习惯于将多叶准直器(MLC)进入LINAC设计的策略的差异方面。然而,这种信息是确定不同LINACS的中子剂量等同物,并计算Vault屏蔽要求。因此,目前研究的目的是从三种制造商的最新LINACS测量中子谱:518,18和20mV,西门子oncor运行的Varian 21ex,在15和18 mV下运行, Elekta精确工作在15和18 mV。通过粘土球体的金箔活化测量中子生产。基于测量,作者确定了中子谱并计算了平均能量,总中子流量,环境剂量等同物和中子源强度。中子谱的形状在促进剂之间或甚至作为治疗能量的函数之间没有显着变化。然而,随着治疗能量的增加,中子流量,因此环境剂量等同物变化,增加。对于给定的名义治疗能量,这些值对于Varian Linac始终最高。因此,目前的研究提供了医学物理学家关于目前在运行中的ULC的LINACS的中子生产的广泛信息,并为其提供了对准确比较和中子剂量等同物的预测的信息,以及拱顶屏蔽要求的计算至关重要。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号